Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Bladder cancer 💬
 [1] BRAF 💬 Dabrafenib 💬 Dabrafenib [1] 34 💬
2 Bladder cancer 💬
 [2] BRAF, RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
3 Bladder cancer 💬
 [1] CDK4 💬 Abemaciclib 💬 Abemaciclib [1] 34 💬
4 Bladder cancer 💬
 [1] EGFR 💬 Cetuximab 💬 Cetuximab [2] 51, 86 💬
5 Bladder cancer 💬
 [1] EGFR 💬 Erlotinib 💬 Erlotinib [1] 94 💬
6 Bladder cancer 💬
 [1] EGFR 💬 Gefitinib 💬 Gefitinib [1] 75 💬
7 Bladder cancer 💬
 [1] EGFR 💬 Icotinib 💬 Icotinib [1] 34 💬
8 Bladder cancer 💬
 [2] EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib [3] 34, 74, 75 💬
9 Bladder cancer 💬
 [2] EGFR, ERBB2 💬 Neratinib 💬 Neratinib [1] 34 💬
10 Bladder cancer 💬
 [2] EGFR, ERBB2 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
11 Bladder cancer 💬
 [1] FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
12 Bladder cancer 💬
 [1] FGFR3 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
13 Bladder cancer 💬
 [2] MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib [1] 34 💬
14 Bladder cancer 💬
 [2] MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib [1] 280 💬
15 Bladder cancer 💬
 [2] MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib [1] 34 💬
16 Bladder cancer 💬
 [2] MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib [1] 34 💬
17 Bladder cancer 💬
 [2] MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib [4]  2 , 34, 279, 280 💬
18 Bladder cancer 💬
 [1] SRC 💬 Bosutinib 💬 Bosutinib [2]  2 , 67 💬
19 Bladder cancer 💬
 [1] SRC 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
20 Bladder cancer 💬
 [1] SRC 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
21 Bladder cancer 💬
 [1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
22 Bladder cancer 💬
 [1] VEGFA 💬 Aflibercept 💬 Aflibercept [2] 90, 166 💬
23 Bladder cancer 💬
 [1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [6] 13, 34, 85, 87, 227, 280 💬
24 Bladder cancer 💬
 [1] VEGFA 💬 Ranibizumab 💬 Ranibizumab [4] 34, 166, 227, 301 💬